Related Experiment Video
Updated: Oct 19, 2025

Author Spotlight: Advancements in Multiplex Detection of Respiratory Viruses
Published on: November 10, 2023
Covid-19, Pregnancy, and Vaccinations
Nola A Holness1, Yolanda M Powell-Young2, Elisa Torres3
1Nicole Wertheim College of Nursing and Health Sciences, Florida International University, AHC-3 Room 323, 1200 SW 8th Street, Miami, FL 33199 nholness@fiu.edu.
Pregnant individuals with COVID-19 face higher risks of severe illness. COVID-19 vaccination is crucial for this high-risk group, yet data on vaccine safety in pregnancy is limited.
Area of Science:
- Obstetrics and Gynecology
- Infectious Diseases
- Vaccinology
Background:
- Pregnancy with COVID-19 elevates risks for severe illness, hospitalization, and need for life support.
- Pregnant women were excluded from initial COVID-19 vaccine trials, creating a data gap on safety and efficacy.
- Contradictory vaccination recommendations for pregnant individuals necessitate urgent data dissemination.
Purpose of the Study:
- To highlight the critical need for COVID-19 vaccine safety data in pregnant populations.
- To address the gap in scientific understanding regarding vaccine use in pregnancy.
- To inform public health strategies for protecting pregnant women from COVID-19.
Main Methods:
- Review of existing scientific literature on COVID-19 in pregnancy.
- Analysis of available data on COVID-19 vaccine safety profiles (mRNA and viral vector).
- Assessment of current vaccination guidelines and recommendations for pregnant women.
Main Results:
- Pregnant women with COVID-19 experience increased morbidity and mortality.
- Current COVID-19 vaccines are believed to be safe for obstetrical and neonatal outcomes.
- Significant inconsistencies exist in current vaccination recommendations for pregnant individuals.
Conclusions:
- Urgent collation and dissemination of vaccine safety data are essential for pregnant women.
- Vaccination is a key strategy to prevent severe COVID-19 illness in this high-risk group.
- Addressing data gaps will advance the health and wellness of pregnant individuals and their neonates.
More Related Videos
07:13Induction of Maternal Immune Activation in Mice at Mid-gestation Stage with Viral Mimic PolyI:C
Published on: March 25, 2016
09:09Generating a Reproducible Model of Mid-Gestational Maternal Immune Activation using PolyI:C to Study Susceptibility and Resilience in Offspring
Published on: August 17, 2022
Related Concept Videos
Vaccinations
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by...
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Teratogenicity
Pharmacokinetics: Drug–Food and Drug–Viral Interactions
Transmission-based Precautions I: Contact, Enteric, and Droplets
Contact Precautions:
Contact precautions are the measures taken to prevent the transmission of infectious agents, especially epidemiologically important microorganisms such as MRSA or influenza, primarily transmitted through direct or indirect contact with an...